FDAnews Drug Daily Bulletin

ALGORX AND CORGENTECH TO MAIL DEFINITIVE PROXY FOR PROPOSED MERGER

Nov. 18, 2005
A A

AlgoRx Pharmaceuticals, Inc. and Corgentech Inc. (Nasdaq: CGTK) today announced that the joint proxy statement/prospectus in connection with the merger transaction involving Corgentech and AlgoRx is being mailed to both companies' stockholders. The companies will convene respective special meetings for stockholders on Thursday, December 15, 2005.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/11-17-2005/0004218310&EDATE=)